These policies may differ from WADA standards
KLOW vials required for a 12-week protocol Note: Two low-dose vials contain enough peptide by mass, but the 12-week schedule spans three 28-day refrigerated-use windows
Last reviewed: July 18, 2026 Last updated: July 18, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Addressing hormone balance, nutrition, stress, and gut health forms the foundation
BPC-157 should be considered experimental, and any use for gut health requires caution, professional guidance, and awareness of the current lack of regulatory approval